Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H32O4 |
| Molecular Weight | 384.5085 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@]1([H])[C@@]3([H])[C@]4([H])[C@]5([H])C[C@]5([H])[C@@](O)(CCC(O)=O)[C@@]4(C)CC[C@]3([H])[C@@]6(C)CCC(=O)C=C26
InChI
InChIKey=LHTVRHFTKRJEQF-HXCATZOESA-N
InChI=1S/C24H32O4/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23,28)8-5-19(26)27/h9,13-16,18,20-21,28H,3-8,10-11H2,1-2H3,(H,26,27)/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1
Drospirenone acid is a metabolite of drospirenone, one of the two main metabolites found in human plasma. Drospirenone is a synthetic progestational compound used as a component of oral contraceptive in combination with ethinyl estradiol (YASMIN®) or ethinyl estradiol/levomefolate calcium (BEYAZ®).
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
91810655
Created by
admin on Sat Dec 16 09:49:07 GMT 2023 , Edited by admin on Sat Dec 16 09:49:07 GMT 2023
|
PRIMARY | |||
|
06412XCN1A
Created by
admin on Sat Dec 16 09:49:07 GMT 2023 , Edited by admin on Sat Dec 16 09:49:07 GMT 2023
|
PRIMARY | |||
|
776251-13-9
Created by
admin on Sat Dec 16 09:49:07 GMT 2023 , Edited by admin on Sat Dec 16 09:49:07 GMT 2023
|
PRIMARY |
PARENT (METABOLITE INACTIVE)
SUBSTANCE RECORD
